These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


363 related items for PubMed ID: 28560160

  • 21. Quantitative assessment of cerebral hemodynamic parameters by QUASAR arterial spin labeling in Alzheimer's disease and cognitively normal Elderly adults at 3-tesla.
    Mak HK, Chan Q, Zhang Z, Petersen ET, Qiu D, Zhang L, Yau KK, Chu LW, Golay X.
    J Alzheimers Dis; 2012; 31(1):33-44. PubMed ID: 22504315
    [Abstract] [Full Text] [Related]

  • 22. Decreased medial temporal oxygen metabolism in Alzheimer's disease shown by PET.
    Ishii K, Kitagaki H, Kono M, Mori E.
    J Nucl Med; 1996 Jul; 37(7):1159-65. PubMed ID: 8965188
    [Abstract] [Full Text] [Related]

  • 23. Calibrated bold fMRI with an optimized ASL-BOLD dual-acquisition sequence.
    Fernández-Seara MA, Rodgers ZB, Englund EK, Wehrli FW.
    Neuroimage; 2016 Nov 15; 142():474-482. PubMed ID: 27502047
    [Abstract] [Full Text] [Related]

  • 24. Comparing cerebrovascular reactivity measured using BOLD and cerebral blood flow MRI: The effect of basal vascular tension on vasodilatory and vasoconstrictive reactivity.
    Halani S, Kwinta JB, Golestani AM, Khatamian YB, Chen JJ.
    Neuroimage; 2015 Apr 15; 110():110-23. PubMed ID: 25655446
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D, Schuff N, Jagust W, Weiner MW, Alzheimer''s Disease Neuroimaging Initiative.
    Neurodegener Dis; 2016 Apr 15; 16(1-2):87-94. PubMed ID: 26560336
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Hemodynamic and metabolic changes during hypercapnia with normoxia and hyperoxia using pCASL and TRUST MRI in healthy adults.
    Deckers PT, Bhogal AA, Dijsselhof MB, Faraco CC, Liu P, Lu H, Donahue MJ, Siero JC.
    J Cereb Blood Flow Metab; 2022 May 15; 42(5):861-875. PubMed ID: 34851757
    [Abstract] [Full Text] [Related]

  • 30. Reduced blood oxygenation level dependent connectivity is related to hypoperfusion in Alzheimer's disease.
    Göttler J, Preibisch C, Riederer I, Pasquini L, Alexopoulos P, Bohn KP, Yakushev I, Beller E, Kaczmarz S, Zimmer C, Grimmer T, Drzezga A, Sorg C.
    J Cereb Blood Flow Metab; 2019 Jul 15; 39(7):1314-1325. PubMed ID: 29431005
    [Abstract] [Full Text] [Related]

  • 31. Calibrated MRI to evaluate cerebral hemodynamics in patients with an internal carotid artery occlusion.
    De Vis JB, Petersen ET, Bhogal A, Hartkamp NS, Klijn CJ, Kappelle LJ, Hendrikse J.
    J Cereb Blood Flow Metab; 2015 Jun 15; 35(6):1015-23. PubMed ID: 25712500
    [Abstract] [Full Text] [Related]

  • 32. Mapping oxidative metabolism in the human brain with calibrated fMRI in health and disease.
    Chen JJ, Uthayakumar B, Hyder F.
    J Cereb Blood Flow Metab; 2022 Jul 15; 42(7):1139-1162. PubMed ID: 35296177
    [Abstract] [Full Text] [Related]

  • 33. Changes in cerebral blood flow and oxygen metabolism related to magnetic resonance imaging white matter hyperintensities in Alzheimer's disease.
    Yamaji S, Ishii K, Sasaki M, Imamura T, Kitagaki H, Sakamoto S, Mori E.
    J Nucl Med; 1997 Sep 15; 38(9):1471-4. PubMed ID: 9293811
    [Abstract] [Full Text] [Related]

  • 34. Longitudinal Cerebral Blood Flow Changes in Normal Aging and the Alzheimer's Disease Continuum Identified by Arterial Spin Labeling MRI.
    Camargo A, Wang Z, Alzheimer’s Disease Neuroimaging Initiative.
    J Alzheimers Dis; 2021 Sep 15; 81(4):1727-1735. PubMed ID: 33967053
    [Abstract] [Full Text] [Related]

  • 35. The potential for gas-free measurements of absolute oxygen metabolism during both baseline and activation states in the human brain.
    Liu EY, Guo J, Simon AB, Haist F, Dubowitz DJ, Buxton RB.
    Neuroimage; 2020 Feb 15; 207():116342. PubMed ID: 31722231
    [Abstract] [Full Text] [Related]

  • 36. Attenuation of functional hyperemia to visual stimulation in mild Alzheimer's disease and its sensitivity to cholinesterase inhibition.
    Janik R, Thomason LA, Chaudhary S, Dorr A, Scouten A, Schwindt G, Masellis M, Stanisz GJ, Black SE, Stefanovic B.
    Biochim Biophys Acta; 2016 May 15; 1862(5):957-65. PubMed ID: 26521151
    [Abstract] [Full Text] [Related]

  • 37. Different post label delay cerebral blood flow measurements in patients with Alzheimer's disease using 3D arterial spin labeling.
    Liu Y, Zeng X, Wang Z, Zhang N, Fan D, Yuan H.
    Magn Reson Imaging; 2015 Nov 15; 33(9):1019-1025. PubMed ID: 26113261
    [Abstract] [Full Text] [Related]

  • 38. Misery perfusion with preserved vascular reactivity in Alzheimer's disease.
    Nagata K, Buchan RJ, Yokoyama E, Kondoh Y, Sato M, Terashi H, Satoh Y, Watahiki Y, Senova M, Hirata Y, Hatazawa J.
    Ann N Y Acad Sci; 1997 Sep 26; 826():272-81. PubMed ID: 9329699
    [Abstract] [Full Text] [Related]

  • 39. A novel perspective to calibrate temporal delays in cerebrovascular reactivity using hypercapnic and hyperoxic respiratory challenges.
    Champagne AA, Bhogal AA, Coverdale NS, Mark CI, Cook DJ.
    Neuroimage; 2019 Feb 15; 187():154-165. PubMed ID: 29217405
    [Abstract] [Full Text] [Related]

  • 40. Brain metabolism in tau and amyloid mouse models of Alzheimer's disease: An MRI study.
    Wei Z, Xu J, Chen L, Hirschler L, Barbier EL, Li T, Wong PC, Lu H.
    NMR Biomed; 2021 Sep 15; 34(9):e4568. PubMed ID: 34050996
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 19.